Science Explorer Back to mapMap
Discussion

ChemoCentryx (United States)

World rank, all time
#32,898
of 34,923
Rank in United States
#6,905
of 7,310
Research works
131
▼ 62% vs 2018-21
Citations
5.5k
42.4 per fractional work
Top-10% rate
8.3%
all institutions 10.0%
vs its own fields
1.05×
1.00× is exactly expected
Open access
46%
world 40%
International
20%
world 18%

Which fields of science does ChemoCentryx (United States) work in?

In all years, 62% of research at ChemoCentryx (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (61%), Immunology and Microbiology (23%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 81 fractional works · 61.7% of its workMedicine: 80 fractional works · 61.3% of its workOncology: 30 fractional works · 23.3% of its workEpidemiology: 7 fractional works · 5.5% of its workPulmonary and Respiratory Medicine: 6 fractional works · 4.3% of its workRadiology, Nuclear Medicine and Imaging: 5 fractional works · 3.5% of its workNephrology: 4 fractional works · 3.2% of its workGenetics: 4 fractional works · 3.2% of its workRheumatology: 4 fractional works · 2.9% of its workPathology and Forensic Medicine: 2 fractional works · 1.7% of its workHematology: 2 fractional works · 1.6% of its workImmunology and Allergy: 2 fractional works · 1.5% of its workDermatology: 2 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 1.3% of its workPhysiology: 2 fractional works · 1.3% of its workSurgery: 2 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.0% of its workPharmacology: 1 fractional works · 1.0% of its workHepatology: 1 fractional works · 0.7% of its workPsychiatry and Mental health: 1 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 44 fractional works · 33.5% of its workImmunology and Microbiology: 30 fractional works · 23.3% of its workImmunology: 29 fractional works · 22.6% of its workParasitology: 1 fractional works · 0.5% of its workVirology: 0 fractional works · 0.2% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 9.1% of its workMolecular Biology: 7 fractional works · 5.4% of its workGenetics: 2 fractional works · 1.9% of its workCancer Research: 1 fractional works · 0.7% of its workClinical Biochemistry: 1 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.3% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 6 fractional works · 4.4% of its workEngineering: 2 fractional works · 1.4% of its workBiomedical Engineering: 1 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.4% of its workAerospace Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 2 fractional works · 1.3% of its workComputational Theory and Mathematics: 1 fractional works · 0.6% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 0.8% of its workOrganic Chemistry: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 1 fractional works · 0.6% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKChemoCentryx(United States)131fractional works, all years
Life Sciences34%Physical Sciences4%Health Sciences62%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine8061.3%
    2. Health Professions00.2%
    3. Nursing00.1%
    4. Dentistry00.1%
    1. Immunology and Microbiology3023.3%
    2. Biochemistry, Genetics and Molecular Biology129.1%
    3. Pharmacology, Toxicology and Pharmaceutics10.5%
    4. Neuroscience10.5%
    5. Agricultural and Biological Sciences00.1%
    1. Engineering21.4%
    2. Computer Science21.3%
    3. Chemistry10.8%
    4. Physics and Astronomy10.6%
    5. Materials Science00.3%
    6. Environmental Science00.1%
    1. Social Sciences00.2%
    2. Psychology00.1%
    3. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.94× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 10.87× its world share, 2 worksImmunology and Micro…Computer Science: 0.78× its world share, 1 worksComputer ScienceEngineering: 0.34× its world share, 1 worksEngineeringMaterials Science: 0.62× its world share, 0 worksMaterials SciencePhysics and Astronomy: 1.27× its world share, 0 worksPhysics and AstronomyDentistry: 0.89× its world share, 0 worksDentistryHealth Professions: 0.16× its world share, 0 worksHealth ProfessionsMedicine: 3.46× its world share, 10 worksMedicineEconomics, Econometrics and Finance: 0.25× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.9×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology10.87×2 works
  2. Medicine3.46×10 works
  3. Physics and Astronomy1.27×0 works
  4. Biochemistry, Genetics and Molecular Biology0.94×1 works
  5. Dentistry0.89×0 works
  6. Computer Science0.78×1 works
  7. Materials Science0.62×0 works
  8. Engineering0.34×1 works
  9. Economics, Econometrics and Finance0.25×0 works
  10. Health Professions0.16×0 works

Who are the top researchers at ChemoCentryx (United States)?

Ranked on the quality score, Thomas J. Schall, Huibin Yue and Pirow J. Bekker lead among researchers whose main affiliation is ChemoCentryx (United States).

  1. 1 Thomas J. Schall United States · #35,125 worldwide 32k citations · 268 works
  2. 2 Huibin Yue United States · #169,035 worldwide 3k citations · 88 works
  3. 3 Pirow J. Bekker United States · #264,249 worldwide 8.4k citations · 118 works
  4. 4 Mark E.T. Penfold United States · #307,315 worldwide 5.3k citations · 47 works
  5. 5 Daniel J. Dairaghi United States · #326,423 worldwide 3.4k citations · 44 works
  6. 6 Zhenhua Miao United States · #620,530 worldwide 3.4k citations · 55 works
  7. 7 Penglie Zhang United States · #732,512 worldwide 2.1k citations · 74 works
  8. 8 Robert Berahovich United States · #892,273 worldwide 1.7k citations · 37 works
  9. 9 Dale Newland United States · #935,093 worldwide 1.4k citations · 21 works
  10. 10 Juan C. Jaén United States · #989,106 worldwide 4.6k citations · 160 works
All ranked researchers at ChemoCentryx (United States)

What are the most cited papers from ChemoCentryx (United States)?

The most cited paper from ChemoCentryx (United States) is "A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development" (Jennifer M. Burns, Bretton C. Summers, Yu Wang et al., 2006), with 1,280 citations. Next come "Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis" (632) and "Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis" (610).

Most cited papers
#PaperReleasedCitations
1 A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development Jennifer M. Burns, Bretton C. Summers, Yu Wang et al. · The Journal of Experimental Medicine Open access 28 Aug 2006 1,280
2 Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis Bi‐Sen Ding, Zhongwei Cao, Raphaël Lis et al. · Nature Open access 19 Nov 2013 632
3 Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis David R.W. Jayne, Annette N. Bruchfeld, Lorraine Harper et al. · Journal of the American Society of Nephrology Open access 11 Apr 2017 610
4 A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo Laura R. Saunders et al. · Science Translational Medicine Open access 26 Aug 2015 606
5 Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study Charles M. Rudin et al. · The Lancet Oncology Open access 5 Dec 2016 578
All 59 most cited papers, with filters and sorting

Which keywords describe research at ChemoCentryx (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Therapeutic Targets, Immune Responses, Cell Migration, Host Defense, Cancer Metastasis and Chemokine Receptors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation36▲ 12×31 topics
  2. Angiogenesis19▲ 35×6 topics
  3. Therapeutic Targets17▲ 57×5 topics
  4. Immune Responses17▲ 133×2 topics
  5. Cell Migration16▲ 144×2 topics
  6. Host Defense16▲ 188×3 topics
  7. Cancer Metastasis16▲ 380×1 topic
  8. Chemokine Receptors16▲ 759×1 topic
  9. Cancer12▲ 6.4×12 topics
  10. Tumor Microenvironment11▲ 23×7 topics
  11. Immunity10▲ 23×4 topics
  12. Innate Immunity9▲ 21×6 topics
  13. TGF-ß6▲ 29×3 topics
  14. Cancer Immunotherapy6▲ 33×3 topics
  15. Immune Response6▲ 7.3×8 topics
  16. Genetics6▲ 5.8×5 topics
  17. Dendritic Cells6▲ 38×2 topics
  18. Immunotherapy6▲ 6.7×10 topics
  19. Glycosylation6▲ 19×2 topics
  20. NK Cell Recognition6▲ 41×1 topic
  21. Natural Killer Cells6▲ 41×1 topic
  22. Antigen Presentation5▲ 40×2 topics
  23. Immune Checkpoint Blockade5▲ 71×1 topic
  24. PD-1 and PD-L15▲ 71×1 topic
  25. Tumor Antigen5▲ 48×1 topic
  26. Vaccine Adjuvants5▲ 48×1 topic
  27. Chemotherapy5▲ 5.1×10 topics
  28. Rituximab5▲ 22×4 topics
  29. Metabolism5▲ 5.5×3 topics
  30. Monoclonal Antibodies5▲ 24×3 topics
  31. Therapeutic Antibodies4▲ 26×2 topics
  32. Activation4▲ 93×1 topic
  33. Antibody Engineering4▲ 33×1 topic
  34. Fc Receptors4▲ 33×1 topic
  35. Macrophage4▲ 58×1 topic
  36. Regulatory T Cells4▲ 28×4 topics
  37. Autoimmunity4▲ 14×4 topics
  38. Immune System4▲ 9.2×3 topics
  39. Thrombosis3▲ 12×3 topics
  40. Metastasis3▲ 7.5×6 topics

Which research topics does ChemoCentryx (United States) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Vasculitis and related conditions, Renal Diseases and Glomerulopathies and Hidradenitis Suppurativa and Treatments.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
  2. 2 Vasculitis and related conditions Pulmonary and Respiratory Medicine 1 works
  3. 3 Renal Diseases and Glomerulopathies Nephrology 1 works
  4. 4 Hidradenitis Suppurativa and Treatments Dermatology 1 works
  5. 5 Chronic Kidney Disease and Diabetes Nephrology 1 works
  6. 6 Colorectal and Anal Carcinomas Surgery 1 works
  7. 7 Complement system in diseases Immunology 1 works
  8. 8 Chemokine receptors and signaling Oncology 1 works
  9. 9 Otitis Media and Relapsing Polychondritis Rheumatology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.3%not open53.7%

World: 40% of research is openly available.

with international co-authors20.3%domestic only79.7%

World: 18% is written across borders.

How has ChemoCentryx (United States)'s research output changed?

Output in 2022-2025 was 62% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ChemoCentryx (United States) as a percentage of every work published that year, 0.000038% in 2024.

still counting0.00010%0.00020%0.00030%ChemoCentryx (United States)0.000014% in 2025200020102020

Fractional works of ChemoCentryx (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mountain View

All research institutions in Mountain View

Share ChemoCentryx (United States)'s ranking

ChemoCentryx (United States) on Science Explorer

A card with ChemoCentryx (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ChemoCentryx (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.